MARKET

ENVB

ENVB

Enveric Biosciences Inc
NASDAQ
1.540
-0.010
-0.65%
Pre Market: 1.516 -0.024 -1.58% 07:19 08/11 EDT
OPEN
1.560
PREV CLOSE
1.550
HIGH
1.580
LOW
1.510
VOLUME
764
TURNOVER
0
52 WEEK HIGH
17.64
52 WEEK LOW
1.250
MARKET CAP
6.20M
P/E (TTM)
-0.0519
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENVB last week (0803-0807)?
Weekly Report · 1d ago
Psychedelic: Compass Pathways, GH Research report quarterly earnings
TipRanks · 4d ago
Enveric Biosciences reports new preclinical data on EB-003
TipRanks · 5d ago
Enveric Biosciences Says New Preclinical Data Confirms Non-Hallucinogenic Profile For Lead Psychiatric Candidate
Benzinga · 5d ago
Enveric Biosciences Announces New Preclinical Data That Further Supports The Non-Hallucinogenic Profile Of EB-003; GloSensor Assay Findings Align With Previously Reported BRET Data
Benzinga · 5d ago
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in July 2026
Seeking Alpha · 08/03 13:45
Weekly Report: what happened at ENVB last week (0727-0731)?
Weekly Report · 08/03 09:22
Enveric ‘welcomes’ final FDA guidance for psychedelic drug development
TipRanks · 07/28 12:05
More
About ENVB
Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its discovery and development platform, the Psybrary platform, which houses proprietary information on the use and development of existing and novel molecules for specific mental health indications, the Company seeks to develop a robust intellectual property portfolio of drug candidates. Its lead molecule, EB-003, is a neuroplastogen designed to promote neuroplasticity, without inducing hallucinations, in patients suffering from difficult-to-address mental health disorders. The Company is focused on advancing EB-003 towards clinical trials for the treatment of neuropsychiatric disorders while out-licensing other Psybrary platform drug candidates to third-party licensees and advancing non-competitive market strategies for patient care.

Webull offers Enveric Biosciences Inc stock information, including NASDAQ: ENVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENVB stock methods without spending real money on the virtual paper trading platform.